Evidence map›Paper›PMID 36989438›Full record

ArticleJournal of the American Chemical Society2023

A Convergent Total Synthesis of (+)-Ineleganolide.

Benjamin M Gross, Seo-Jung Han, Scott C Virgil, Brian M Stoltz

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Asymmetric Total Synthesis of (+)-Ineleganolide.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Short, Enantioselective Total Synthesis of (+)-Ineleganolide.Journal of the American Chemical Society · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Benjamin M GrossThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, California Institute of Technology, MC-101-20, Pasadena, California 91125, United States.ORCID 0000-0002-9124-2317
Seo-Jung HanThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, California Institute of Technology, MC-101-20, Pasadena, California 91125, United States.ORCID 0000-0002-5812-3826
Scott C VirgilThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, California Institute of Technology, MC-101-20, Pasadena, California 91125, United States.
Brian M StoltzThe Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, California Institute of Technology, MC-101-20, Pasadena, California 91125, United States.ORCID 0000-0001-9837-1528
California Institute of Technology · US

Funding

The Synthesis of Bioactive Natural Products as a Driving Force for Discovery in Organic ChemistryR35GM145239 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BRIAN M STOLTZ · 2022 to 2026
$3.1M
NIGMS NIH HHS R35 GM145239
6 · The paper itself

Abstract

We report the total synthesis of the furanobutenolide-derived diterpenoid (+)-ineleganolide. The synthetic approach relies on a convergent strategy based on the coupling of two enantioenriched fragments, which are derived from (-)-linalool and (+)-norcarvone, respectively. A high-yielding, one-step Michael addition and aldol cascade furnishes a pentacyclic framework as a single diastereomer, thereby overcoming previous challenges in controlling stereochemistry. The endgame features an O

Indexed as

DiterpenesCyclizationOxidation-ReductionDiterpenesineleganolide

Identifiers

PMID36989438
PMCPMC10544024
OpenAlexW4361283527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.